ACHE
acetylcholinesterase (Yt blood group)
Summary
Acetylcholinesterase hydrolyzes the neurotransmitter, acetylcholine at neuromuscular junctions and brain cholinergic synapses, and thus terminates signal transmission. It is also found on the red blood cell membranes, where it constitutes the Yt blood group antigen. Acetylcholinesterase exists in multiple molecular forms which possess similar catalytic properties, but differ in their oligomeric assembly and mode of cell attachment to the cell surface. It is encoded by the single ACHE gene, and the structural diversity in the gene products arises from alternative mRNA splicing, and post-translational associations of catalytic and structural subunits. The major form of acetylcholinesterase found in brain, muscle and other tissues is the hydrophilic species, which forms disulfide-linked oligomers with collagenous, or lipid-containing structural subunits. The other, alternatively spliced form, expressed primarily in the erythroid tissues, differs at the C-terminal end, and contains a cleavable hydrophobic peptide with a GPI-anchor site. It associates with the membranes through the phosphoinositide (PI) moieties added post-translationally. AChE activity may constitute a sensitive biomarker of RBC ageing in vivo, and thus, may be of aid in understanding the effects of transfusion[provided by RefSeq, Sep 2019]
Known Variants39 total
| rsid | Position (GRCh37) | Alleles | Class | ClinVar |
|---|---|---|---|---|
| rs17228616 | 7:100,487,721 | G/T | regulatory region variant | — |
| rs17886728 | 7:100,488,638 | G/T | — | likely benign |
| rs2571598 | 7:100,489,639 | C/T | downstream gene variant | — |
| rs760239221 | 7:100,490,017 | C/T | — | likely benign |
| rs1584773209 | 7:100,490,058 | A/G | — | uncertain significance |
| rs151107784 | 7:100,490,074 | G/A | — | likely benign |
| rs7636 | 7:100,490,077 | G/A | synonymous variant | — |
| rs145811992 | 7:100,490,093 | A/G | — | uncertain significance |
| rs546907479 | 7:100,490,130 | C/T | — | likely benign |
| rs148991713 | 7:100,490,136 | C/T | — | uncertain significance |
| rs550436794 | 7:100,490,185 | G/A | — | likely benign |
| rs1375989925 | 7:100,490,250 | C/T | — | uncertain significance |
| rs370742086 | 7:100,490,273 | T/C | — | uncertain significance |
| rs2485506334 | 7:100,490,283 | C/G | — | uncertain significance |
| rs772297940 | 7:100,490,348 | C/G | — | uncertain significance |
| rs1799805 | 7:100,490,797 | G/T | missense variant | benign |
| rs144995873 | 7:100,490,810 | G/A | — | likely benign |
| rs2116000213 | 7:100,490,821 | C/T | — | uncertain significance |
| rs17880119 | 7:100,490,822 | C/T | — | benign |
| rs375157729 | 7:100,490,940 | C/T | — | uncertain significance |
| rs1584774926 | 7:100,491,008 | C/G | — | likely benign |
| rs17228581 | 7:100,491,047 | C/T | — | benign |
| rs764412723 | 7:100,491,063 | T/C | — | uncertain significance |
| rs1320833786 | 7:100,491,128 | C/T | — | uncertain significance |
| rs2485514670 | 7:100,491,324 | A/G | — | uncertain significance |
| rs144426398 | 7:100,491,361 | C/T | — | uncertain significance |
| rs146564868 | 7:100,491,415 | C/T | — | uncertain significance |
| rs1359240864 | 7:100,491,450 | G/C | — | uncertain significance |
| rs17885778 | 7:100,491,451 | G/C | — | likely benign |
| rs114367422 | 7:100,491,588 | C/T | — | benign |
| rs375017123 | 7:100,491,700 | G/T | — | uncertain significance |
| rs17881553 | 7:100,491,753 | C/T | — | benign |
| rs2485519393 | 7:100,491,772 | C/T | — | uncertain significance |
| rs369950352 | 7:100,491,814 | C/T | — | uncertain significance |
| rs145798043 | 7:100,491,904 | G/A | upstream gene variant | — |
| rs3808356 | 7:100,492,322 | C/T | regulatory region variant | — |
| rs17881696 | 7:100,493,359 | G/A | regulatory region variant | — |
| rs17883557 | 7:100,494,949 | G/T | regulatory region variant | — |
| rs76181418 | 7:100,494,960 | G/T | regulatory region variant | — |
Gene information from NCBI Gene. Variant classifications from ClinVar.